BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 09, 2023	Sep. 10, 2022	Sep. 09, 2023	Sep. 10, 2022
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,290.7	$ 17,919.4	$ 42,340.9	$ 41,229.7
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,290.7	$ 17,919.4	$ 42,340.9	$ 41,229.7
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,236.9	$ 9,004.5	$ 21,323.7	$ 20,450.5
Percentage of total net sales and other revenue	50.50%	50.30%	50.40%	49.60%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,919.4	$ 5,944.5	$ 13,808.7	$ 13,826.0
Percentage of total net sales and other revenue	32.40%	33.20%	32.60%	33.50%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,741.0	$ 1,476.3	$ 4,041.1	$ 3,399.8
Percentage of total net sales and other revenue	9.50%	8.20%	9.50%	8.30%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,126.8	$ 1,202.8	$ 2,527.2	$ 2,857.5
Percentage of total net sales and other revenue	6.10%	6.70%	6.00%	6.90%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 266.6	$ 291.3	$ 640.2	$ 695.9
Percentage of total net sales and other revenue	1.50%	1.60%	1.50%	1.70%